Several studies have cited the Mediterranean diet as an example of healthy eating. In fact, the Mediterranean diet has become the reference diet for the prevention of cardiovascular disease. Red wine seems to be an essential component of the diet, since moderate consumption of wine is associated with lower risk and mortality from cardiovascular disease. Evidence is also accumulating that wine helps prevent the development of certain cancers. Of all the many components of wine, resveratrol, which is a natural component specifically present in wine, has been identified as being mainly responsible for these health-promoting properties. Many valuable properties such as cardioprotective and anticarcinogenic activity have been attributed to resveratrol; however, its bioavailability is quite low. The bioactivity of metabolites derived from resveratrol, and the accumulation of resveratrol in vital organs are still under study, but there are high expectations of positive results. Other stilbene compounds are also considered in this review, despite being present in undetectable or very small quantities in wine. The present paper reviews all aspects of the health properties of wine, bioactive compounds found in wine, and their concentrations, bioavailability and possible synergistic effects.
KeyA. (1980) Seven countries: a multivariable analysis of death and coronary heart disease.Harvard University Press, Cambridge, UK.
2.
RenaudS, De LorgerilM. (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet, 339, 1523–1526.
3.
De LorgerilM, SalenP, Caillat-ValletE, HanauerMT, BarthelemyJC, MamelleN. (1997) Control of bias in dietary trial to prevent coronary recurrences: The Lyon Diet Heart Study. European Journal of Clinical Nutrition, 51, 116–122.
4.
De LorgerilM, SalenP, MartinJL, MonjaudI, BoucherP, MamelleN. (1998) Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate. Archives of International Medicine, 158, 1181–1187.
5.
De LorgerilM, SalenP, MartinJL, BoucherF, PaillardF, de LeirisJ. (2002) Wine drinking and risks of cardiovascular complications after recent acute myocardial infarction. Circulation, 106, 1465–1469.
6.
LaironD. (2007) Intervention studies on Mediterranean diet and cardiovascular risk. Molecular Nutrition & Food Research, 51, 1209–1214.
7.
TrichopoulouA. (2004) Traditional Mediterranean diet and longevity in the elderly: a review. Public Health Nutrition, 7, 943–947.
8.
SkoumasJ, PitsavosC, PanagiotakosDB, ChrysohoouC, ZeimbekisA, PapaioannouI, ToutouzaM, ToutouzasP, StefanadisC. (2003) Physical activity, high density lipoprotein cholesterol and other lipids levels, in men and women from the ATTICA study. Lipids in Health and Disease, 12, 2–3.
9.
SofiF, CesariF, AbbateR, GensiniGF, CasiniA. (2008) Adherence to Mediterranean diet and health status: meta-analysis. British Medical Journal, 337, 1344–1351.
10.
CarluccioMA, SiculellaL, AncoraMA, MassaroM, ScodittiE, StorelliC, VisioliF, DistanteA, de CaterinaR. (2003) Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arteriosclerosis Thrombosis, and Vascular Biology, 23, 622–629.
11.
PitsavosC, PanagiotakosDB, ChrysohoouC, KokkinosPF, SkoumasJ, PapaioannouI, StefanadisC, ToutouzasP (2002) The effect of the combination of Mediterranean diet and leisure time physical activity on the risk of developing acute coronary syndromes, in hypertensive subjects. Journal of Human Hypertension, 16, 517–524.
12.
BoyleP, FerlayJ. (2005) Mortality and survival in breast and colorectal cancer. Nature Clinical Practice. Oncology, 2, 424–425.
13.
La VecchiaC, BosettiC. (2006) Diet and cancer risk in Mediterranean countries: open issues. Public Health Nutrition, 9, 1077–1082.
14.
TrichopoulouA, CostacouT, BamiaC, TrichopoulosD. (2003) Adherence to a Mediterranean diet and survival in a Greek population. The New England Journal of Medicine, 348, 2599–2608.
15.
WillettWC, SacksF, TrichopoulouA, DrescherG.Ferro-LuzziA, HelsingE, TrichopoulosD. (1995) Mediterranean diet pyramid: a cultural model for healthy eating. The American Journal of Clinical Nutrition, 61(6 Suppl), 1402S–1406S.
16.
AvelloneG, Di GarboV, CampisiD, De SimoneR, RaneliG, ScaglioneR, LicataG. (2006) Effects of moderate Sicilian red wine consumption on inflammatory biomarkers of atherosclerosis. European Journal of Clinical Nutrition, 60, 41–47.
17.
LeightonF, CuevasA, GuaschV, PerezDD, StrobelP, San MartinA, UrzuaU, DiezMS, FonceaRCastilloO, MizonC, EspinozaMA, UrquiagaI, RozowskiJ, MaizA, GermainA. (1999) Plasma polyphenols and antioxidants, oxidative DNA damage, and endothelial function in a diet and wine intervention study in humans. Drugs under Experimental and Clinical Research, 25, 133–141.
18.
MezzanoD, LeightonF, MartinezC, MarshallG, CuevasA, CastilloO, PanesO, MunozB, PerezDD, MizonC, RozowskiJ, San MartinA, PereiraJ. (2001) Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors. European Journal of Clinical Nutrition, 55, 444–451.
19.
RimmEB, StampferMJ, GiovannucciE, AscherioA, SpiegelmanD, ColditzGA, WillettWC. (1995) Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. American Journal of Epidemiology, 141, 1117–1127.
20.
MarfellaR, CacciapuotiF, SiniscalchiM, SassoFC, MarcheseF, CinoneF, MusacchioE, MarfellaMA, RuggieroL, ChiorazzoG, LibertiD, ChiorazzoG, NicolettiGF, SaronC, D'AndreaF, AmmendolaC, VerzaM, CoppolaL. (2006) Effect of moderate red wine intakes on cardiac prognosis after recent acute myocardial infarction of subjects with type 2 diabetes mellitus. Diabetic Medicine, 23, 974–981.
21.
BriggsNC, LevineRS, BoboLD, HaliburtonWP, BrannEA, HennekensCH. (2002) Wine drinking and risk of non- Hodgkin's lymphoma among men in the United States: a population-based case-control study. American Journal of Epidemiology, 156, 454–462.
22.
PlatzEA, LeitzmannMF, RimmEB, WillettWC, GiovannucciE. (2004) Alcohol intake, drinking patterns, and risk of prostate cancer in a large prospective cohort study. American Journal of Epidemiology, 159, 444–453.
23.
SchoonenWM, SalinasCA, KiemeneyLA, StanfordJL. (2005) Alcohol consumption and risk of prostate cancer in middle-aged men. International Journal of Cancer, 113, 133–140.
24.
SchurmanAG, GoldbohmRA, Van den BrandtPA. (1999) A prospective cohort study on consumption of alcoholic beverages in relation to prostate cancer incidence (The Netherlands). Cancer Causes Control, 10, 597–605.
25.
GammonMD, SchoenbergJB, AhsanH, RischHA, VaughanTL, ChowWH, RotterdamH, WestAB, DubrowR, StanfordJL, MayneST, FarrowDC, NiwaS, BlotWJ, FraumeniJFJr. (1997) Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. Journal of the National Cancer Institute, 89, 1277–1284.
26.
BessaoudF, DauresJP. (2008) Patterns of alcohol (especially wine) consumption and breast cancer risk: a case -control study among a population in Southern France. Annals of Epidemiology, 18, 467–475.
27.
SutcliffeS, GiovannucciE, LeitzmannMF, RimmEB, StampferMJ, WillettWC, PlatzEA. (2007) A prospective cohort study of red wine consumption and risk of prostate cancer. International Journal of Cancer, 120, 1529–1535.
28.
LongneckerMP, OrzaMJ, AdamsME, VioqueJ, ChalmersTC. (1990) A meta-analysis of alcoholic beverage consumption in relation to risk of colorectal cancer. Cancer Causes Control, 1, 59–68.
29.
LugasiA, HovariJ. (2003) Antioxidant properties of commercial alcoholic and nonalcoholic beverages. Nahrung, 47, 79–86.
30.
ThirunavukkarasuM, PenumathsaSV, SamuelSM, AkitaY, ZhanL, BertelliAA, MaulikG, MaulikN. (2008) White wine induced cardioprotection against ischemia-reperfusion injury is mediated by life extending Akt/FOXO3a/NFkappaB survival pathway. Journal of Agricultural and Food Chemistry, 56, 6733–6739.
31.
PerezDD, StrobelP, FonceaR, DiezM, Soledad-VezL, UrquiagaI, CastilloO, CuevasA, San MartinA, LeightonF. (2002) Wine, diet, antioxidant defences, and oxidative damage. Annals of the New York Academy of Sciences, 957(Alcohol and Wine in Health and Disease), 136–145.
32.
EngET, YeJJ, WilliamsD, PhungS, MooreRE, YoungMK, UgisG, BraunsteinG, ChenS. (2003) Suppression of estrogen biosynthesis by procyanidin dimmers in red wine and grape seeds. Cancer Research, 63, 8516–8522.
33.
VisioliF, GrandeS, BoganiP, GalliC. (2004) The role of antioxidants in the mediterranean diets: focus on cancer. European Journal of Cancer Prevention: the official journal of the European Cancer Prevention Organisation (ECP), 13, 337–343.
34.
BurnsJ, CrozierA, LeanMEJ. (2001) Alcohol consumption and mortality: is wine different from other alcoholic beverages?Nutrition, Metabolism and Cardiovascular Diseases, 11, 249–258.
35.
LongneckerMP, EngerSM. (1996) Epidemiologic data on alcoholic beverage consumption and risk of cancer. Clinica Chimica Acta; International Journal of Clinical Chemistry, 246, 121–141.
36.
BoursiB, ArberN. (2007) Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention. Current Pharmaceutical Design, 13, 2274–2282.
37.
McEligotAJ, LargentJ, ZiogasA, PeelD, Anton-CulverH. (2006) Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer. Nutrition and Cancer, 55, 132–140.
38.
SeitzHK, BeckerP. (2007) Alcohol metabolism and cancer risk. Alcohol Research & Health: The Journal of the National Institute on Alcohol Abuse and Alcoholism, 30, 38-41, 44–47.
39.
GronbaekM, BeckerU, JohansenD, GottschauA, SchnohrP, HeinHO, JenesenG, SorensenTIA. (2000) Type of alcohol consumed and mortality from all causes, coronary heart disease and cancer. Annals Internal Medicine, 133, 411–419.
40.
CorraoG, RubbiatiL, BagnardiV, ZambonA, PoikolainenK. (2000) Alcohol and coronary heart disease: a meta-analysis. Addiction, 95, 1505–1523.
41.
KlatskyAL. (2001) Should patients with heart disease drink alcohol?Journal of the American Association, 285, 2004–2006.
42.
HinesLM, StampferMJ, MaJ, GazianoJM, RidkerPM, HankinsonSE, SacksF, RimmEB, HunterDJ. (2001) Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. New England Journal of Medicine, 344, 549–555.
43.
MukamalKJ, KronmalRA, MittlemanMA, O'LearyDH, PolakJF, CushmanMS, DavidS. (2003) Alcohol Consumption and Carotid Atherosclerosis in Older Adults. The cardiovascular health study. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 2252–2259.
44.
GazianoJM. (1999) Do antioxidants protect against cardiovascular disease?Preventive Cardiology, 2, 59–66.
45.
SaccoRL. (1999) Secondary prevention of ischemic stroke: A 1998 US perspective. Cerebrovascular Diseases (Basel, Switzerland), 9(Suppl 3), 37–44.
46.
Di CastelnuovoA, RotondoS, IacovierlloL, DonatiMB, De GaetanoG. (2002) Metaanalysis of wine and beer consumption in relation to vascular risk. Circulation, 195, 2836–2844.
47.
EstruchR. (2000) Wine and cardiovascular disease. Food Research International, 33, 219–226.
48.
Rodríguez-ArtalejoF, Guallar-CastillonP, BanegasJR, de Andres-ManzanoB, Del Rey-CaleroJ. (1998) Consumption of fruit and wine and the decline in cerebrovascular disease mortality in Spain (1975–1993). Stroke, 29, 1556–1561.
49.
Blanco-ColioLM, ValderramaM, Alvarez-SalaLA, BustosC, OrtegoM, Hernández-PresaMA, CancelasP, Gomez-GeriqueJ, MillanJ, EgidoJ. (2000) Red wine prevents nuclear factor κβ activation in peripheral blood mononuclear cells of healthy volunteers during postprandrial lipemia. Circulation, 102, 1020–1026.
50.
CorderR, DouthwaiteJA, LeesDM, KhanNQ, Dos SantosACV, WoodEG, CarierMJ. (2001) Endothelin-1 synthesis reduced by red wine. Nature, 414, 863–864.
51.
Al-AwwadiNA, BornetA, AzayJ, AraizC, DelboscS, CristolJP, LinckN, CrosG, TeissedrePL, (2004) Red wine polyphenols alone or in association with ethanol prevent hypertension, aardiac hypertrophy, and production of reactive oxygen species in the insulin-resistant fructose-fed rat. Journal of Agricultural and Food Chemistry, 52, 5593–5597.
52.
CliffordAJ, EbelerSE, EbelerJD, BillsND, HinrichsSH, TeissedrePL, WaterhouseAL. (1996) Delayed tumor onset in transgenic mice fed an amino acid-based diet supplemented with red wine solids. American Journal of Clinical Nutrition, 64, 748–756.
53.
DowneyMO, DokoozlianNK, KrsticMP. (2006) Cultural practice and environmental impacts on the flavonoid composition of grapes and wine: a review of recent research. American Journal of Enology and Viticulture, 57, 257–268.
54.
MazzaG. (1995) Anthocyanins in grapes and grapes products. Critical Reviews in Food Science, 35, 341–371.
55.
WaterhouseAL. (2002) Wine phenolics. Annals of the New York Academy of Sciences, 957, 21–36.
56.
ZafrillaP, MorillasJ, MuleroJ, CayuelaJM, Martinez-CachaA, PardoF, Lopez-NicolasJM. (2003) Changes during storage in conventional and ecological wine: phenolic content and antioxidant activity. Journal of Agricultural and Food Chemistry, 51, 4694–4700.
57.
CarandoS, TeissedrePL, Waffo-TeguoP, CabanisJC, DeffieuxG, MerillonJM. (1999) High-performance liquid chromatography coupled with fluorescence detection for the determination of trans-astringin in wine. Journal of Chromatography A, 849, 617–620.
58.
ChamkhaM, CathalaB, CheynierV, DouillardR. (2003) Phenolic composition of champagnes from chardonnay and pinot noir vintages. Journal of Agricultural and Food Chemistry, 51, 3179–3184.
59.
MonagasM, BartolomeB, Gomez-CordovesC. (2005) Updated knowledge about the presence of phenolic compounds in wine. Critical Reviews in Food Science and Nutrition, 45, 85–118.
60.
Pour NikfardjamMS, PickeringGJ. (2008) Influence of variety and commercial yeast preparation on red wine made from autochthonous Hungarian and Canadian grapes. Part I: phenolic composition. European Food Research and Technology, 227, 1077–1083.
CartronE, FouretG, CarbonneauMA, LauretC, MichelF, MonnierL, DescompsB, LegerCL. (2003) Red-wine beneficial long-term effect on lipids but not on antioxidant characteristics in plasma in a study comparing three types of wine-description of two O-methylated derivatives of gallic acid in humans. Free Radical Research, 37, 1021–1035.
63.
UrsiniF, SevanianA. (2002) Wine polyphenols and optimal nutrition. Annals of the New York Academy of Sciences, 957, 200–209.
64.
StocletJC, ChataigneauT, NdiayeM, OakMH, El BedouiJ, ChataigneauM, Schini-KerthVB. (2004) Vascular protection by dietary polyphenols. European Journal of Pharmacology, 500, 299–313.
65.
HeS, SunC, PanY. (2008) Red wine polyphenols for cancer prevention. International Journal of Molecular Sciences, 9, 842–853.
66.
PedersenA, JohansenC, GronbaekM. (2003) Relations between amount and type of alcohol and colon and rectal cancer in a Danish population based cohort study. Gut, 52, 861–867.
67.
DolaraP, LuceriC, De FilippoC, FemiaAP, GiovannelliL, CaderniG, CecchiniC, SilviS, OrpianesiC, CresciA. (2005) Red wine polyphenols influence carcinogenesis, intestinal microflora, oxidative damage and gene expression profiles of colonic mucosa in F344 rats. Mutation Research, 591, 237–246.
68.
NielsenIL, CheeWS, PoulsenL, Offord-CavinE, RasmussenSE, FrederiksenH, EnslenM, BarronD, HorcajadaMN, WilliamsonG. (2006) Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: a randomized, double-blind, crossover trial. Journal of Nutrition, 136, 404–408.
69.
ScholzS, WilliamsonG. (2007) Interactions affecting the bioavailability of dietary polyphenols in vivo. International Journal for Vitamin and Nutrition Research, 77, 224–235.
70.
ManachC, WilliamsonG, MorandC, ScalbertA, RemesyC. (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. The American Journal of Clinical Nutrition, 81(1 Suppl), 230S–242S.
71.
McGhieTK, WaltonMC. (2007) The bioavailability and absorption of anthocyanins: towards a better understanding. Molecular Nutrition & Food Research, 51, 702–713.
72.
BootsAW, HaenenGRMM, BastA. (2008) Health effects of quercetin: From antioxidant to nutraceutical. European Journal of Pharmacology, 585, 325–337.
73.
DuarteJ, Perez-PalenciaR, VargasF, OceteMA, Perez-VizcainoF, ZarzueloA, TamargoJ. (2001) Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. British Journal of Pharmacology, 133, 117–124.
74.
DuarteJ, JimenezR, O'ValleF, GalisteoM, Perez-PalenciaR, VargasF, Perez-VizcainoF, ZarzueloA, TamargoJ. (2002) Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. Journal of Hypertension, 20, 1843–1854.
75.
OkamotoT. (2005) Safety of quercetin for clinical application (review). International Journal of Molecular Medicine, 16, 275–278.
76.
McAnlisGT, McEnenyJ, PearceJ, YoungIS. (1999) Absorption and antioxidant effects of quercetin from onions, in man. European Journal of Clinical Nutrition, 53, 92–96.
OttavianiJI, Actis-GorettaL, VillordoJJ, FragaCG. (2006) Procyanidin structure defines the extent and specificity of angiotensin I converting enzyme inhibition. Biochimie, 88, 359–365.
79.
LowryJB, McSweeneyCS, PalmerB. (1996) Changing perceptions of the effect of plant phenolics on nutrient supply in the ruminant. Australian Journal of Agricultural Research, 47, 829–842.
80.
HayekT, FuhrmanB, VayaJ, RosenblatM, BelinkyP, ColemanR, ElisA, AviramM. (1997) Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 2744–2752.
81.
RuidavetsJB, TeissedrePL, FerrieresJ, CarandoS, BougardG, CabanisJC. (2000) Catechin in the Mediterranean diet: vegetable, fruit or wine?Atherosclerosis, 153, 107–117.
82.
WilliamsonG, ManachC. (2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. American Journal of Clinical Nutrition, 81(1S), 243S–255S.
83.
LuceriC, GianniniL, LodoviciM, AntonucciE, AbbateR, MasiniE, DolaraP. (2007) p-Coumaric acid, a common dietary phenol, inhibits platelet activity in vitro and in vivo. British Journal of Nutrition, 97, 458–463.
84.
TomeraJF. (1999) Current knowledge of the health benefits and disadvantages of wine consumption. Trends in Food Science & Technology, 10, 129–138.
85.
CovasMI, Miro-CasasE, FitoM, Farre-AlbadalejoM, GimenoE, MarrugatJ, De La TorreR. (2003) Bioavailability of tyrosol, an antioxidant phenolic compound present in wine and olive oil, in humans. Drug Under Experimental and Clinical Research, 29, 203–206.
86.
VisioliF, GalliC, BornetF, MatteiA, PatelliR, GalliG, CarusoD. (2000) Olive oil phenolics are dose-dependently absorbed in humans. FEBS Letters, 468, 159–160.
87.
NorataGD, MarchesiP, PassamontiS, PirilloA, VioliF, CatapanoAL. (2007) Anti-inflammatory and antiatherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis, 191, 265–271.
88.
PignatelliP, GhiselliA, BuchettiB, CarnevaleR, NatellaF, GermanoG, FimognariF, Di SantoS, LentiL, VioliF. (2006) Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine. Atherosclerosis, 188, 77–83.
89.
TakaokaMJ. (1940) Of the phenolic substances of white hellebore (Veratrum grandiflorum Loes. fil.). Journal of the Faculty of Science, Hokkaido Imperial University, 3, 1–16.
90.
LangcakeP, PryceRJ. (1976) The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiological Plant Pathology, 9, 77–86.
91.
SiemannEH, CreasyLL. (1992) Concentration of the phytoalexin resveratrol in wine. American Journal of Enology and Viticulture, 43, 49–52.
92.
AsensiM, MedinaI, OrtegaA, CarreteroJ, BanoMC, ObradorE, EstrelaJM. (2002) Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radical Biology and Medicine, 33, 387–398.
93.
JangMS, CaiEN, UdeaniGO, SlowingKV, ThomasCF, BeecherCWW, FongHHS, FarnsworthNR, KinghornAD, MehtaRG, MoonRC, PezzutoJM. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218–220.
94.
BradamanteS, BarenghiL, VillaA. (2004) Cardiovascular protective effects of resveratrol. Cardiovascuar Drug Review, 22, 169–188.
ValenzanoDR, TerzibasiE, GenadeT, CattaneoA, DomeniciL, CellerinoA. (2006) Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Current Biology, 16, 296–300.
97.
HarborneJB. The comparative biochemistry of phytoalexins induction in plants. (1999) Biochemical Systematics and Ecology, 27, 335–367.
98.
LyonsMM, YuC, TomaRB, ChoSY, ReiboldtW, LeeJ, Van BreemenRB. (2003) Resveratrol in raw and baked blueberries and bilberries. Journal of Agricultural and Food Chemistry, 51, 5867–5870.
99.
WangZ, HuangY, ZouJ, CaoK, XuY, WuJM. (2002) Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. International Journal of Molecular Medicine, 9, 77–79.
100.
BurnsJ, GardnerPT, YokotaT, AshiharaH, LeanME, CrozierA. (2002) Plant foods and herbal sources of resveratrol. Journal of Agricultural and Food Chemistry, 50, 3337–3340.
101.
TokusogluO, UnalMK, YemisF. (2005) Determination of the phytoalexin resveratrol (3,5,4′-trihydroxystilbene) in peanuts and pistachios by high performance liquid chromatographic diode array (HPLC-DAD) and gas chromatography-mass spectrometry (GC-MS). Journal of Agricultural and Food Chemistry, 53, 5003–5009.
102.
CounetC, CallemienD, CollinS. (2006) Chocolate and cocoa: new sources of trans-resveratrol and trans-piceid. Food Chemistry, 98, 649–657.
103.
CantosE, EspínJC, Tomás-BarberánFA. (2002) Postharvest stilbene-enrichment of red and white table grape varieties using UV-C irradiation pulses. Journal of Agricultural and Food Chemistry, 50, 6322–6329.
104.
Romero-PérezAI, Ibern-GomézM, Lamuela-RaventósRM, de la Torre-BoronatMC. (1999) Piceid, the major resveratrol derivative in grape juices. Journal of Agricultural and Food Chemistry, 47, 1533–1536.
105.
Romero-PérezA, Lamuela-RaventósRM, WaterhouseAL, de la Torre-BoronatMC. (1996) Levels of cis- and trans-resveratrol and their glucosides in white and rosé Vitis vinifera wines from Spain. Journal of Agricultural and Food Chemistry, 44, 2124–2128.
106.
Lamuela-RaventósRM, Romero-PérezAI, WaterhouseAL, De la Torre-BoronatMC. (1995) Direct HPLC analysis of cis- and trans- resveratrol and piceid isomers in Spanish red Vitis vinifera wines. Journal of Agricultural and Food Chemistry, 43, 281–283.
107.
LandraultN, LarrondeF, DelaunayJC, CastagninoC, VercauterenJ, MerillonJM, GascF, CrosG, TeissedrePL. (2002) Levels of stilbene oligomers and astilbin in French wines and grapes during noble rot development. Journal of Agricultural and Food Chemistry, 50, 2046–2052.
108.
StervboU, VangO, BonnesenC. (2006) Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells. Cell Proliferation, 39, 479–493.
109.
BavarescoL. (2003) Role of viticultural factors on stilbene concentrations of grapes and wine. Drugs under experimental and clinical research, 29, 181–187.
110.
SoleasGJ, GoldbergDM, KarumanchiriA, DiamandisEP, NgE. (1995) Influences of viticultural and enological factors on changes in cis- and trans-resveratrol in commercial wines. Journal of Wine Research, 6, 107–121.
111.
VrhovsekU, WendelinS, EderR. (1997) Effects of various vinification techniques on the concentration of cis- and trans-resveratrol and resveratrol glucoside isomers in wine. American Journal of Enology and Viticulture, 48, 214–219.
112.
FrémontL. (2000) Biological effects of resveratrol. Life Science, 66, 663–673.
113.
StervboU, VangO, BonnesenC. (2007) A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine. Food Chemistry, 101, 449–457.
114.
GoldbergDM, NgE, KarumanchiriA, DiamandisEP, SoleasGJ. (1996) Resveratrol glucosides are important components of commercial wines. American Journal of Enology and Viticulture, 47, 415–420.
115.
RoldánA, PalaciosV, CaroI, PérezL. (2003) Resveratrol content of Palomino Fino grapes: influence of vintage and fungal infection. Journal of Agricultural and Food Chemistry, 51, 1464–1468.
116.
SoleasGJ, DiamandisEP, GoldbergDM. (1997) Wine as a biological fluid: history, production, and role in disease prevention. Journal of Clinical Laboratory Analysis, 11, 287–313.
117.
IritiM, RossoniM, BorgoM, FaoroF. (2004) Benzothiadiazole enhances resveratrol and anthocyanin biosynthesis in grapevine, meanwhile improving resistance to botrytis cinerea. Journal of Agricultural and Food Chemistry, 52, 4406–4413.
CantosE, Tomás-BarberánFA, MartínezA, EspínJC. (2003) Differential stilbene induction susceptibility of seven red wine grape varieties upon postharvest UV-C irradiation. European Food Research and Technology, 217, 253–258.
120.
González-CandelasL, GilJV, Lamuela-RaventósRM, RamónD. (2000) The use of transgenic yeast expressing a gene encoding a glycosyl-hydrolase as a tool to increase resveratrol content in wine. International Journal of Food Microbiology, 59, 179–183.
121.
BeckerJVW, ArmstrongGO, Van der MerweMJ, LambrechtsMG, VivierMA, PretoriousIS. (2003) Metabolic engineering of Saccharomyces cerevisiae for the synthesis of the wine-related antioxidant resveratrol. FEMS Yeast Research, 4, 79–85.
122.
ZhangY, LiSZ, LiJ, PanX, CahoonRE, JaworskiJG, WangX, JezJM, ChenF, YuO. (2006) Using unnatural protein fusions to engineer resveratrol biosynthesis in yeast and mammalian cells. Journal of the American Chemical Society, 128, 13030–13031.
123.
PoutaraudA, LatoucheG, MartinsS, MeyerS, MerdinogluD, CerovicZG. (2007) Fast and local assestment of stilbene content in grapevine leaf by in vivo fluorometry. Journal of Agricultural and Food Chemistry, 55, 4913–4920.
124.
BuiarelliF, CoccioliF, JasionowskaR, MerolleM, TerraccianoA. (2007) Analysis of some stilbenes in Italian wines by liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry, 21, 2955–2964.
125.
GüebailiaHA, ChiraK, RichardT, MabroukT, FurigaA, VitracX, MontiJP, DelaunayJC, MerillonJM. (2006) Hopeaphenol: the first resveratrol tetramer in wines from north Africa. Journal of Agricultural and Food Chemistry, 54, 9559–9564.
126.
Ribeiro de LimaMT, Waffo-TeguoP, TeissedrePL, PujolasA, VercauterenJ, CabanisJC, MérillonJM. (1999) Determination of stilbenes (trans-astringin, cis- and trans-piceid, and cis- and trans-resveratrol) in Portuguese wines. Journal of Agricultural and Food Chemistry, 47, 2666–2670.
127.
VitracX, BornetA, VanderlindeR, VallsJ, RichardT, DelaunaJC, MerillonJM, TeissedrePL. (2005) Determination of stilbenes (δ-viniferin, trans-astringin, trans-piceid, cis- and trans-resveratrol, ∊-viniferin) in Brazilian wines. Journal of Agricultural and Food Chemistry, 53, 5664–5669.
128.
PezetR, GindroK, ViretO, SpringJL. (2004) Glycosylation and oxidative dimerization of resveratrol are respectively associated to sensitivity and resistance of grapevine cultivars to downy mildew. Physiological and Molecular Plant Pathology, 65, 297–303.
129.
VitracX, MontiJP, VercauerenJ, DeffieuxG, MérillonJM. (2002) Direct liquid chromatographic analysis of resveratrol derivates and flavonols in wines with absorbance and fluorescence detection. Analytica Chimica Acta, 458, 103–110.
130.
Waffo-TeguoP, FauconneauB, DeffieeuxC, HuguetF, VercauterenJ, MerillonJM. (1998) Isolation, identification and antioxidant active of three stilbene glycosides newly extracted from Vitis vinifera cell cultures. Journal of Natural Products, 61, 655–657.
131.
ArichiH, KimuraY, OkudaH, BabaK, KozawaM, ArichiS. (1982) Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chemical and Pharmaceutical Bulletin, 30, 1766–1770.
132.
RiviereC, RichardT, QuentinL, KrisaS, MerillonJM, MontiJP. (2007) Inhibitory activity of stilbenes on Alzheimer's β- amyloid fibrils in vitro. Bioorganic & Medicinal Chemistry, 15, 1160–1167.
133.
MengX, MaliakalP, LuH, LeeMJ, YangCS. (2004) Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. Journal of Agricultural and Food Chemistry, 52, 935–942.
134.
VitaglioneP, SforzaS, GalavernaG, GhidiniC, CaporasoN, VescoviPP, FoglianoV, MarchelliR. (2005) Bioavailability of trans-resveratrol from red wine in humans. Molecular Nutrition and Food Research, 49, 495–504.
135.
HungLM, SuMJ, ChuWK, ChiaoCW, ChanWF, ChenJK. (2002) The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. British Journal of Pharmacology, 135, 1627–1633.
KuoPL, HsuYL. (2008) The grape and wine constituent piceatannol inhibits proliferation of human bladder cancer cells via blocking cell cycle progression and inducing Fas/membrane bound Fas ligand-mediated apoptotic pathway. Molecular Nutrition & Food Research, 52, 408–418.
138.
PiverB, FerM, VitralX, MérillonJM, DreanoY, BerthouF, LucasD. (2004) Involment of cytochrome P450 1A2 in the transformation of trans-resveratrol in human liver microsomes. Biochememical Pharmacology, 68, 773–782.
139.
HungLM, ChenJK, LeeRS, LiangHC, SuMJ. (2001) Beneficial effects of astringinin, a resveratrol analogue, on the ischemia and reperfusion damage in rat heart. Free Radical Biology & Medicine, 30, 877–883.
140.
FuZD, CaoY, WangKF, XuSF, HanR. (2004) Chemopreventive effect of resveratrol to cancer. Ai Zheng, 23, 869–873.
141.
SchoeppnerA, KindlH. (1979) Stilbene synthase (pinosylvin synthase) and its induction by ultraviolet light. FEBS Letters, 108, 349–352.
142.
AdrianM, JeandetP, Douillet-BreuilAC, TessonL, BessisR. (2000) Stilbene content of mature Vitis vinifera berries in response to UV-C elicitation. Journal of Agricultural and Food Chemistry, 48, 6103–6105.
143.
PezetR, PontV. (1988) Demonstration of pterostilbene in clusters of Vitis vinifera. Plant Physiology and Biochemistry, 26, 603–607.
144.
TolomeoM, GrimaldoS, Di CristinaA, RobertiM, PizzaraniD, MeliM, DusonchetL, GebbiaN, AbbadessaV, CrostaL, BarucchelloR, GrisoliaG, InvidiataF, SimoniD. (2005) Pterostilbene and 3′-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. The International Journal of Biochemistry and Cell Biology, 37, 1709–1726.
145.
Ros-BarceloA, PomarF, Lopez-SerranM, PedrenoMA. (2003) Peroxidase: a multifunctional enzyme in grapevines. Functional Plant Biology, 30, 577–591.
146.
OshimaY, NamaoK, KamijouA, MatsuokaS, NakanoM, TeraoK, OhizumiY. (1995) Powerful hepatoprotective and hepatotoxic plant oligostilbenes, isolated from the Oriental medicinal plant Vitis coígnetíae (Vitaceae). Experiencia, 51, 63–66.
147.
PrivatC, TeloJP, Bernardes-GenissonV, VieiraA, SouchardJP, NepveuF. (2002) Antioxidant properties of trans-∊-viniferin as compared to stilbene derivates in aqueous media. Journal of Agricultural and Food Chemistry, 50, 1213–1217.
148.
BilliardC, IzardJC, RomanV, KernC, MathiotC, MentsF, KolbJP. (2002) Comparative antiproliferative and apoptotic effects of resveratrol, ∊-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukaemia cells and normal human lymphocytes. Leukemia & Lymphoma, 43, 1991–2002.
149.
PiverB, BerthouF, DreanoY, LucasD. (2003) Differential inhibition of human cytochrome P450 enzymes by ∊-viniferin, the dimmer of resveratrol: comparison with resveratrol and polyphenols from alcoholised beverages. Life Sciences, 73, 1199–1213.
150.
YañezM, FraizN, CanoE, OralloF. (2006) (-)-Trans-∊ -viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake, and of monoamine oxidase activity. European Journal of Pharmacology, 542, 54–60.
151.
Douillet-BreuilA, JeandetP, AdrianM, BessisR. (1999) Changes in the phytoalexin content of various Vitis spp. in response to ultraviolet C elicitation. Journal of Agricultural and Food Chemistry, 47, 4456–4461.
152.
RayneS, KaracabeyE, MazzaG. (2008) Grape cane waste as a source of trans-viniferin: High value phytochemicals with medicinal and anti-phytopathoenic applications. Industrial Crops and Products, 27, 335–340.
153.
TakayaY, YanKX, TerashimaK, HeYH, NiwaM. (2002) Biogenetic reactions on stilbene tetramers from Vitaceaeous plants. Tetrahedron, 58, 9265–9271.
154.
Zamora-RosR, Andres-LacuevaC, Lamuela-RaventósRM, BerenguerT, JakszynP, MartínezC, SánchezMJ, NavarroC, ChirlaqueMD, TormoMJ, QuirósJR, AmianoP, DorronsoroM, LarrañagaN, BarricarteA, ArdanazE, GonzálezCA. (2008) Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort. British Journal of Nutrition, 100, 188–196.
155.
WalleT, HsiehF, DeLeggeMH, OatisJE, WalleUK. (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabolism and Disposition, 32, 1377–1382.
156.
MarierJF, VachonP, GritsasA, ZhangJ, MoreauJP, DucharmeMP. (2002) Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. Journal of Pharmacology and Experimental Therapeutics, 302, 369–373.
157.
Urpi-SardaM, JaureguiO, Lamuela-RaventosRM, JaegerW, MiksitsM, CovasMI, Andres-LacuevaC. (2005) Uptake of diet resveratrol into the human low-density lipoprotein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry. Analytical Chemistry, 77, 3149–55.
158.
BertelliAAE, GiovanniniL, StradiR, BertelliA, TillementJP. (1996) Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4′,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. International Journal of Tissue Reaction, 18, 67–71.
159.
BertelliAAE. (2007) Wine, research and cardiovascular disease: instructions for use. Atherosclerosis, 195, 242–247.
160.
BertelliA, BertelliAAE, GozziniA, GiovanniniL. (1998) Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs under experimental and clinical research, 24, 133–138.
161.
ChenY, TsengSH, LaiHS, ChenWJ. (2004) Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice. Surgery, 136, 57–66
JanninB, MenzelM, BerlotJP, DelmasD, LanconA, LatruffeN. (2004) Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake. Biochemical Pharmacology, 68, 1113–1118.
164.
El-MohsenMA, BayeleH, KuhnleG, GibsonG, DebnamESraiSK; Rice-EvansC, SpencerJPE. (2006) Distribution of [3H]trans-resveratrol in rat tissues following oral administration. British Journal of Nutrition, 96, 62–70.
165.
VitracX, DesmouliereA, BrouillaudB, KrisaS, DeffieuxG, BartheN, RosenbaumJ, MerillonJM. (2003) Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sciences, 72, 2219–2233.
166.
De SantiC, PietrabissaA, SpisniR, MoscaF, PacificiGM. (2000) Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum. Xenobiotica, 30, 609–617.
167.
Mertens-TalcottSU, PercivalSS. (2005) Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Letters, 218, 141–51.
168.
ChanMM, MattiacciJA, HwangHS, ShahA, FongD. (2000) Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochemical Pharmacology, 60, 1539–1548.
169.
FangJG, LuM, ChenZH, ZhuHH, LiY, YangL, WuLM, LiuZL. (2002) Antioxidant effects of resveratrol and its analogues against the free-radical-induced peroxidation of linoleic acid in micelles. Chemistry, 8, 4191–4198.
170.
ConteA, PellegriniS, TagliazucchiD. (2003) Synergistic protection of PC12 cells from β-amyloid toxicity by resveratrol and catechin. Brain Research Bulletin, 62, 29–38.
171.
HerediaA, DavisC, RedfieldR. (2000) Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol. Journal of Acquired Immune Deficiency Syndromes, 25, 246–255.
172.
VivancosM, MorenoJJ. (2008) Effect of resveratrol, tyrosol and β-sitosterol on oxidized low-density lipoprotein-stimulated oxidative stress, arachidonic acid release and prostaglandin E2 synthesis by RAW 264.7 macrophages. British Journal of Nutrition, 99, 1199–1207.
173.
GoldbergDM, YanJ, SoleasGJ. (2003) Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clinical Biochemistry, 36, 79–87.
174.
JuanME, VinardellMP, PlanasJM. (2002) The daily oral administration, of high doses of trans-resveratrol to rats for 28 days is not harmful. Journal of Nutrition, 132, 257–260.
175.
ArthurPG, NiuX, RigbyP, SteerJH, JeffreyGP. (2008) Oxidative stress causes a decline in lysosomal integrity during hypothermic incubation of rat hepatocytes. Free Radical Biology & Medicine, 44, 24–33.
176.
LiY, CaoZ, ZhuH. (2006) Up-regulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacological Research, 53, 6–15.
177.
WenzelE, SoldoT, ErbersdoblerH, SomozaV. (2005) Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Molecular Nutrition and Food Research, 49, 482–494.
178.
WhiteheadTP, RobinsonD, AllawayS, SymsJ, HaleA. (1995) Effect of red wine ingestion on the antioxidant capacity of serum. Clinical Chemistry, 41, 32–35.
FrankelEN, KannerJ, GermanJB, ParksE, KinsellaJE. (1993) Inhibition of oxidation of human low density lipoprotein by phenolic substances in red wine. Lancet, 341, 454–457.
184.
BertelliAAE, GiovanniniL, GiannessiD, MiglioriM, BerniniW, FregoniM, BertelliA. (1995) Antiplatelet activity of synthetic and natural resveratrol in red wine. International Journal of Tissue Reactions, 17, 1–3.
185.
WangZ, ZouJ, CaoK, HsiehT, HuangY, WuJM. (2005) Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. International Journal of Molecular Medicine, 16, 533–540.
186.
LiHF, ChenSA, WuSN. (2000) Evidence for the stimulatory effect of resveratrol on Ca2+-activated K+ current in vascular endothelial cells. Cardiovascular Research, 45, 1035–1045.
187.
OralloF, AlvarezE, CaminaM, LeiroJM, GomezE, FernandezP. (2002) The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Molecular Pharmacology, 61, 294–302.
188.
RayPS, MaulikG, CordisGA, BertelliAA, BertelliA, DasDK. (1999) The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radical Biology and Medicine, 27, 160–169.
189.
FloreaniM, NapoliE, QuintieriL, PalatiniP. (2003) Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity. Life Science, 72, 2741–2750.
190.
AggarwalB, BhardwajA, AggarwalRS, SeeramNP, ShishodiaS, TakadaY. (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Research, 24, 2783–2840.
191.
SchneiderY, DurantonB, GosseF, SchleifferR, SeilerN, RaulF. (2001) Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutrition and Cancer, 39, 102–107.
192.
GarvinS, OllingerK, DabrosinC. (2006) Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Letter, 231, 113–122.
193.
AtharM, BackJH, TangX, KimKH, KopelovichL, BickersDR, KimAL. (2007) Resveratrol: A review of preclinical studies for human cancer prevention. Toxicology and Applied Pharmacology, 224, 274–283.
194.
KimuraY, OkudaH. (2001) Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. Journal of Nutrition, 131, 1844–1849.
195.
HechtSS, KenneyPMJ, WangM, TrushinN, AgarwalS, Venket RaoA, UpadhyayaP. (1999) Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Letters, 137, 123–130.
196.
MartinezME, O'BrienTG, FultzKE, BabbarN, YerushalmiH, QuN, GuoY, BoormanD, EinspahrJ, AlbertsDS, GernerEW. (2003) Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proceedings of the National Academy of Sciences USA, 100, 7859–7864.
197.
SchneiderY, VincentF, DurantonB, BadoloL, GosséF, BergmannC, SeilerN, RaulF. (2000) Antiproliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Letters, 158, 85–91.
198.
Smith-WarnerSA, SpiegelmanD, YaunSS, Van den BrandtPA, FolsomAR, GoldbohmRA, GrahamS, HolmbergL, HoweGR, MarshallJR, MillerAB, PotterJD, SpeizerFE, WillettWC, WolkA, HunterDJ. (1998) Alcohol and breast cancer in women: a pooled analysis of cohort studies. Journal of the American Medical Association, 279, 535–540.
199.
Smith-WarnerS, SpiegelmanD, AdamiH-O. (2001) Types of dietary fat and breast cancer: a pooled analysis of cohort studies. International Journal of Cancer, 92, 767–774.
200.
Smith-WarnerS, SpiegelmanD, YaunSS. (2001) Intake of fruits and vegetables and risk of breast cancer. A pooled analysis of cohort studies. Journal of the American Medical Association, 285, 769–776.
201.
ScarlattiF, SalaG, SomenziG, SignorelliP, SacchiN, GhidoniR. (2003) Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. The FASEB Journal, 17, 2339–2341.
202.
ProvincialiM, ReF, DonniniA, OrlandoF, BartozziB, Di StasioG, SmorlesiA. (2005) Effect of resveratrol on the development of spontaneous mammary tumours in HER-2/neu transgenic mice. International Journal of Cancer, 115, 36–45.
203.
LeviF, PascheC, LucchiniF, GhidoniR, FerraroniM, La VecchiaC. (2005) Resveratrol and breast cancer risk. European Journal of Cancer Prevention: the official journal of the European Cancer Prevention Organisation (ECP), 14, 139–142.
204.
MahadyGB, PendlandSL. (2000) Resveratrol inhibits the growth of Helicobacter pylori in vitro. American Journal of Gastroenterology, 95, 1849.
205.
RilesWL, EricksonJ, NayyarS, AttenMJ, AttarBM, HolianO. (2006) Resveratrol engages selective apoptotic signals in gastric adenocarcinoma cells. World Journal of Gastroenterology, 12, 5628–5634.
206.
AzizMH, NihalM, FuVX, JarrardDF, AhmadN. (2006) Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins. Molecular Cancer Therapeutics, 5, 1335–1341.
207.
LinHY, ShihA, DavisFB, TangHY, MartinoLJ, BennettJA, DavisPJ. (2002) Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. The Journal of Urology, 168, 748–755.
208.
SalaG, MinutoloF, MacchiaM, SacchiN, GhidoniR. (2003) Resveratrol structure and ceramide-associated growth inhibition in prostate cancer cells. Drugs under Experimental and Clinical Research, 29, 263–269.
209.
WangTTY, HudsonTS, WangTC, RemsbergCM, DaviesNM, TakahashiY, KimYS, SeifriedH, VinyardBT, PerkinsSN, HurstingSD. (2008) Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis, 29, 2001–2010.
210.
Von LöwEC, PeraboFG, SienerR, MüllerSC. (2007) Review. Facts and fiction of phytotherapy for prostate cancer: a critical assessment of preclinical and clinical data. In Vivo, 21, 189–204.
211.
De VriesE, BrayFI, CoeberghJWW, ParkinDM, JechovaM, StormHH, QuinnM, AareleidT, HakulinenT, SchoutenL, AndersenA, ZatonskiW, BrewsterD, PleskoI, Pompe-KimV, BarlowL, Mace-LesechJ, ArveuxP, FaivreJ, RaverdyN, SauvageM, PaciE, De LisiV, GafaL, ZenettiR, BerrinoF, GarciaCM, ArdanazE, BorrasJ, TorhorstJ, BouchardyC, LeviFG, FischT, SchuelerG. (2003) Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: Rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. International Journal of Cancer, 107, 119–126.
212.
NilesRM, McFarlandM, WeimerMB, RedkarA, FuYM, MeadowsGG. (2003) Resveratrol is a potent inducer of apoptosis in human melanoma cells. Cancer Letters, 190, 157–163.
213.
AzizMH, Reagan-ShawS, WuJ, LongleyBJ, AhmadN. (2005) Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?FASEB Journal, 19, 1193–1195.
214.
LiZG, HongT, ShimadaY, KomotoI, KawabeA, DingY, KaganoiJ, HashimotoY, ImamuraM. (2002) Suppression of nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis, 23, 1531–1536.
215.
ZhouHB, YanY, SunYN, ZhuJR. (2003) Resveratrol induces apoptosis in human oesophageal carcinoma cells. World Journal of Gastroenterology, 9, 408–411.
216.
ShihA, DavisFB, LinHY, DavisPJ. (2002) Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. Journal of Clinical Endocrinology Metabolism, 87, 1223–1232.
217.
MouriaM, GukovskayaAS, JungY, BuechlerP, HinesOJ, ReberHA, PandolSJ. (2002) Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. International Journal of Cancer, 98, 761–769.
218.
KuroiwaY, NishikawaA, KitamuraY, KankiK, IshiiY, UmemuraT, HiroseM. (2006) Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters. Cancer Letters, 241, 275–280.
219.
CaoZ, FangJ, XiaC, ShiX, JiangBH. (2004) trans-3,4,5′- trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells. Clinical Cancer Research, 10, 5253–5263.
220.
DurrantD, RichardsJE, WalkerWT, BakerKA, SimoniD, LeeRM. (2008) Mechanism of cell death induced by cis-3,4 ‘,5-trimethoxy-3 ‘-aminostilbene in ovarian cancer. Gynecologic Oncology, 110, 110–117.
221.
MichelsG, WatjenW, WeberN, NieringP, ChovolouY, KampkoetterA, ProkschP, KahlR. (2006) Resveratrol induces apoptotic cell death in rat H4IIE hepatoma cells but necrosis in C6 glioma cells. Toxicology, 225, 173–182.
222.
MiuraD, MiuraY, YagasakiK. (2003) Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats. Life Sciences, 73, 1393–1400.
223.
WuSL, SunZJ, YuL, MengKW, QinXL, PanCE. (2004) Effect of resveratrol and in combination with 5-FU on murine liver cancer. World Journal of Gastroenterology, 10, 3048–3052.
224.
AtharM, AnKP, MorelKD, KimAL, AszterbaumM, LongleyJ, EpsteinEHJr, BickersDR. (2001) Ultraviolet B(UVB)-induced cox-2 expression in murine skin: an immunohistochemical study. Biochemical and Biophysical Research Communications, 280, 1042–1047.
225.
HorvathZ, SaikoP, IllmerC, MadlenerS, HoechtlT, BauerW, ErkerT, JaegerW, Fritzer-SzekeresM, SzekeresT. (2005) Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukaemia cells. Experimental Hematology, 33, 329–335.
226.
GaoX, XuYX, DivineG, JanakiramanN, ChapmanRA, GautamSC. (2002) Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. Journal of Nutrition, 132, 2076–2081.
227.
GehmBD, McAndrewsJM, ChienPY, JamesonJL. (1997) Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proceedings of the National Academy of Sciences of U.S.A., 94, 14138–14143.
228.
KlingeCM, BlankenshipKA, RisingerKE, BhatnagarS, NoisinEL, SumanasekeraWK, ZhaoL, BreyDM, KeyntonRS. (2005) Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. Journal of Biological Chemistry, 280, 7460–7468.
229.
KingRE, BomserJA, MinDB. (2006) Bioactivity of resveratrol. Comprehensive Reviews in Food Science and Food Safety, 5, 65–70.
230.
BhatKP, LantvitD, ChristovK, MehtaRG, MoonRC, PezzutoJM. (2001) Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Research, 61, 7456–7463.
231.
BaslyJP, Marre-FournierF, Le BailJC, HabriouxG, ChuliaAJ. (2000) Estrogenic/antiestrogenic and scavenging properties of (E)-and (Z)-resveratrol. Life Science, 66, 769–777.
232.
ChenG, ShanW, WuY, RenL, DongJ, JiZ. (2005) Synthesis and anti-inflammatory activity of resveratrol analogs. Chemical and Pharmaceutical Bulletin, 53, 1587–1590.
233.
RahmanI, BiswasSK, KirkhamPA. (2006) Regulation of inflammation and redox signaling by dietary polyphenols. Biochememical Pharmacology, 72, 1439–1452.
234.
SinclairD. (2005) Sirtuins for healthy neurons. Nature Genetics, 37, 339–340.
KarlssonJ, EmgardM, BrundinP, BurkittMJ. (2000) Trans-resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: electron paramagnetic resonance spin trapping evidence for a radical scavenging mechanism. Journal of Neurochemistry, 75, 141–150.
237.
DongW, LiN, GaoD, ZhenH, ZhangX, LiF. (2008) Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. Journal of Vascular Surgery, 48, 709–714.
